MedTrace Logo

Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery

NCT02004613 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 798

Last updated 2021-04-06

Study results available
· View outcomes & findings →

Summary

Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery

Conditions

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine

DRUG

Placebo

Normal saline administration matching dexmedetomidine rate of infusion

Sponsors & Collaborators

  • Hospira, now a wholly owned subsidiary of Pfizer

    collaborator INDUSTRY

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Alparslan Turan, MD · Staff member

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2018-12-31
Completion
2020-12-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02004613 on ClinicalTrials.gov